Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K12 | Q12852 | 18/20 | 0.48 |
| ▸ | MTOR | P42345 | 2/20 | 0.43 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21658973 | 0.83 | MAP3K12 (0.48) | MAP3K12 | |
| SCHEMBL3432392 | 0.80 | MAP3K12 (0.52) | MAP3K12MTORPIK3CA | |
| SCHEMBL21658974 | 0.78 | MAP3K12 (0.40) | MAP3K12MTORPIK3CA | |
| SCHEMBL21658975 | 0.74 | MAP3K12 (0.41) | MAP3K12MTORPIK3CA | |
| SCHEMBL28497461 | 0.74 | PIK3CA (0.49) | MTORPIK3CA | |
| SCHEMBL22074957 | 0.73 | MAP3K12 (0.41) | MAP3K12MTORPIK3CA | |
| SCHEMBL22074961 | 0.69 | MAP3K12 (0.50) | MAP3K12 | |
| SCHEMBL3432395 | 0.66 | MAP3K12 (0.52) | MAP3K12 | |
| SCHEMBL2577774 | 0.66 | MAP3K12 (0.49) | MAP3K12MTORPIK3CA | |
| SCHEMBL16210488 | 0.65 | MAP3K12 (1.00) | MAP3K12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11129832-B2 | Biheteroaryl compounds and uses thereof | GENENTECH, INC. (US) | 2021-09-28 | — | — | US | disclosed |
| US-20200188397-A1 | BIHETEROARYL COMPOUNDS AND USES THEREOF | GENENTECH, INC. (US) | 2020-06-18 | — | — | US | disclosed |
| US-RE47848-E1 | Biheteroaryl compounds and uses thereof | GENENTECH, INC. (US) | 2020-02-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11129832-B2 | Biheteroaryl compounds and uses thereof | BCHE, SNCA, HAX1 | MAP3K12 1980/4885MTOR 3221/4885PIK3CA 3863/4885 |
| US-20200188397-A1 | BIHETEROARYL COMPOUNDS AND USES THEREOF | BCHE, SNCA, HAX1 | MAP3K12 1980/4885MTOR 3221/4885PIK3CA 3863/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.